Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction
This paper is about a way of correction of endothelial dysfunction with the inhibitor of arginase: L-norvaline. There is an imbalance between vasoconstriction and vasodilatation factors of endothelium on...
Saved in:
Main Authors: | Mihail V. Pokrovskiy, Mihail V. Korokin, Svetlana A. Tsepeleva, Tatyana G. Pokrovskaya, Vladimir V. Gureev, Elena A. Konovalova, Oleg S. Gudyrev, Vladimir I. Kochkarov, Liliya V. Korokina, Eleonora N. Dudina, Anna V. Babko, Elena G. Terehova |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.4061/2011/515047 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthesis of Arginase Inhibitors: An Overview
by: Maria Cristina Molaro, et al.
Published: (2025-01-01) -
Reconstruction of self-oscillating systems with delay time modulation
by: Ponomarenko, Vladimir Ivanovich, et al.
Published: (2025-01-01) -
Arginase-1-specific T cells target and modulate tumor-associated macrophages
by: Mads Hald Andersen, et al.
Published: (2025-01-01) -
ON THE ISSUE OF ASSESSING THE ECOLOGICAL STATE OF VARIOUS WATERCOURCES IN THE CONDITIONS OF ANTHROPOGENIC PRESSURE
by: Elena A. Shashulovskaya, et al.
Published: (2021-04-01) -
Comparative Evaluation of Enalapril and Losartan in Pharmacological Correction of Experimental Osteoporosis and Fractures of Its Background
by: D. S. R. Rajkumar, et al.
Published: (2013-01-01)